Personalis at Immuno-Oncology 360 – 2020: February 26-28
Presentation
Erin Newburn, MS, PhD
Associate Director, Field Application Scientist
Thursday, February 27 | 2:40 PM
Comprehensive Immunogenomics to Enable Composite Biomarkers for Immunotherapy Response
- Predicting patient response to immunotherapies requires a robust approach to tumor immunogenomics
- By combining highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics, ImmunoID NeXT provides a broad view of the tumor and the immune-related components of the tumor microenvironment from a single sample preparation
- In this presentation, we’ll discuss the benefits of this unique, innovative design for immuno-oncology translational research including mastering challenging samples, utilizing optimized algorithms, and obtaining accurate genomic data for identifying novel composite biomarkers
